Parabilis Medicines, Inc. Interest Expense Nonoperating
Parabilis Medicines, Inc. (PBLS) reported Interest Expense Nonoperating of $210.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- Parabilis Medicines, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $210.00K, a 46.97% decline year-over-year.
- Parabilis Medicines, Inc. interest expense nonoperating for the quarter ending 2025-06-30 was $396.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month |
|---|---|---|
| 2026-06-30 | $210.00K 10-Q · filed 2026-08-13 | $502.00K 10-Q · filed 2026-08-13 |
| 2025-06-30 | $396.00K 10-Q · filed 2026-08-13 | $795.00K 10-Q · filed 2026-08-13 |